Related Experiment Videos
Fluorescence readouts in HTS: no gain without pain?
Philip Gribbon1, Andreas Sewing
1Lead Discovery Technologies, Pfizer Global Research and Development, Ramsgate Road, Sandwich, UK CT13 9NJ. philip_gribbon@sandwich.pfizer.com
Drug Discovery Today
|December 24, 2003
Summary
Fluorescence detection is vital for sensitive biological tests. This review addresses challenges in assay development and offers solutions to minimize errors in fluorescence-based high-throughput screening (HTS).
Area of Science:
- Biotechnology
- Assay Development
- Biochemistry
Background:
- Fluorescence detection offers sensitive, homogeneous assays in miniaturized formats for biological testing.
- Widespread use reveals challenges in reagent design and interference from biological components.
Purpose of the Study:
- To review current fluorescence-based detection methodologies.
- To focus on assay developer challenges and solutions for reducing false results in fluorescence-based high-throughput screening (HTS).
Main Methods:
- Literature review of fluorescence-based detection technologies.
- Analysis of common problems in assay development for HTS.
- Identification of strategies to mitigate false positives and negatives.
Main Results:
- Assay developers face significant hurdles with reagent design and biological interference.
- Specific solutions are needed to improve the reliability of fluorescence-based assays.
- Reducing false results is crucial for accurate HTS outcomes.
Conclusions:
- Optimizing fluorescence-based detection requires addressing reagent limitations and interference.
- Implementing targeted solutions can enhance the accuracy and efficiency of HTS.
- Further research into robust assay design is essential for advancing biological testing.